title: Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.
abstract: BACKGROUND
  In addition to the negative effect on fertility, polycystic ovary syndrome (PCOS) has been associated with cardiac pathology. Brain natriuretic peptide (BNP) is a possible marker for cardiac risk, therefore we investigated whether N-terminal pro-B-type BNP (NT-proBNP) increases in women with PCOS compared with healthy women of comparable age and body mass index.
  
  
  METHODS
  Thirty women with PCOS and 30 healthy women not suffering from overt cardiac disease were involved in the study. Fasting insulin and serum NT-proBNP levels were measured, and M-Mode echocardiography was performed. Insulin resistance was calculated using the homeostasis model assessment insulin resistance index (HOMA-IR).
  
  
  RESULTS
  PCOS subjects had higher NT-proBNP levels than the control subjects (P < 0.001). Abnormal echocardiography indices were detected in 14 of the PCOS subjects (but none of the controls), including valvular heart disease in nine, diastolic dysfunction in two, right ventricular enlargement in one, right atrial enlargement in one and pulmonary hypertension in one. PCOS subjects (n = 30) showed an increased left ventricular mass (LVM) (P < 0.001) and left ventricular posterior wall thickness (LVPWT) (P = 0.006). In addition, NT-proBNP concentration was positively correlated with LVM (r = 0.587, P = 0.001) and negatively correlated with sex-hormone-binding globulin (r = -0.528, P = 0.003). There was a positive correlation between LVM and HOMA-IR (r = 0.295, P = 0.03) while LVPWT was positively correlated with fasting insulin and HOMA-IR (r = 0.335, P = 0.031 and r = 0.346, P = 0.045, respectively) in PCOS subjects (n = 30).
  
  
  CONCLUSIONS
  The present study demonstrated that the level of NT-proBNP was increased in PCOS subjects with asymptomatic heart disease.
authors.affiliation: Department of Obstetrics and Gynecology, Medical Faculty, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey. oncelik@inonu.edu.tr
authors.forename: Onder
authors.initials: O
authors.lastname: Celik
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Sahin
authors.forename: Nilufer
authors.initials: N
authors.lastname: Celik
authors.forename: Seyma
authors.initials: S
authors.lastname: Hascalik
authors.forename: Lezzan
authors.initials: L
authors.lastname: Keskin
authors.forename: Hamdi
authors.initials: H
authors.lastname: Ozcan
authors.forename: Ahmet
authors.initials: A
authors.lastname: Uckan
authors.forename: Feridun
authors.initials: F
authors.lastname: Kosar
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000378:metabolism; D002319:Cardiovascular System; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D004452:Echocardiography / Q000379:methods; D005260:Female; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D020097:Natriuretic Peptide, Brain / Q000096:biosynthesis*; D010446:Peptide Fragments / Q000096:biosynthesis*; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000150:complications / Q000175:diagnosis*; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D007328:Insulin; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain